Moderna and Merck's Cancer Vaccine Triumphs in Melanoma Trial

Hey, everyone! Moderna and Merck just pulled off a massive win with their personalized mRNA cancer vaccine, showing it can keep melanoma from returning! In a thrilling Phase 3 trial, they proved this treatment can help high-risk patients, giving their immune systems the ultimate training to fight back! This is just the beginning, and they're gearing up to tackle even more cancers, believe it!